Researchers confirm genetic alteration that triggers prostate cancer in mice and man

Jan 28, 2008

A team of researchers led by Valeri Vasioukhin, Ph.D., and Peter Nelson, M.D., both investigators in the Human Biology Division at Fred Hutchinson Cancer Research Center, has confirmed that a molecular change found in human prostate cancers triggers the growth of prostate cancer in mice and in human cell lines. Their findings will be published Jan. 28 in the online early edition of the Proceedings of the National Academy of Sciences.

A significant proportion of human prostate cancers carry a chromosomal rearrangement that results in the overexpression of the ETS transcription factor ERG, a protein that controls gene expression. Until now, the functional significance of this event has been poorly understood.

Studying prostate cells in transgenic mice, Vasioukhin, Nelson and colleagues at the Hutchinson Center and the University of Washington found that up-regulation of ERG transcript initiates cancer growth. They found a similar effect in human prostate cells. They hypothesize that up-regulation of ERG in human prostate cancer activates cell-invasion programs, causing the displacement of basal cells by neoplastic epithelium, or cancerous tissue.

As such, they suggest that ERG should be considered as a target for prostate-cancer prevention or early therapeutic intervention.

Source: Fred Hutchinson Cancer Research Center

Explore further: New chemical technology boosts potency of targeted cancer therapy

Related Stories

New target for anticancer drugs—RNA

Apr 06, 2015

Most of today's anticancer drugs target the DNA or proteins in tumor cells, but a new discovery by University of California, Berkeley, scientists unveils a whole new set of potential targets: the RNA intermediaries ...

Recommended for you

Vortex device makes for better cancer treatments

13 hours ago

A South Australian invention, responsible for unboiling an egg, has been used to produce a four-fold increase in efficacy of carboplatin, a commonly used drug for ovarian, lung and other cancer. ...

Using healthy skin to identify cancer's origins

May 21, 2015

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and de ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.